Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
about
Exercise Prevention of Cardiovascular Disease in Breast Cancer SurvivorsCardiac toxicity in cancer survivorsPotential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer DrugsPET Metabolic Biomarkers for CancerNotch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failureCancer treatment-related cardiac toxicity: prevention, assessment and management.Adult Acute Myeloid Leukemia Long-term Survivors.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.Late effects in childhood cancer survivors: a review with a framing effect bias?Using cardiac biomarkers and treating cardiotoxicity in cancer.Cardiac toxicity of anticancer agents.Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults.Development of Metabolic Syndrome Associated to Cancer Therapy: Review.A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia.Effects of treatment with chemotherapy and/or tamoxifen on the biomarkers of cardiac injury and oxidative stress in women with breast cancer.Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.Cardiac complications of chemotherapy: role of biomarkers.Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase.Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation.A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity.Network and Pathway Analysis of Toxicogenomics Data
P2860
Q26785410-AB7BF40C-1630-432D-A91A-D83BA21DF08FQ26851957-C9591395-45C5-40D4-BF55-E4A549AD9F0FQ28070311-E92FE925-C993-4EE7-88F8-836A56D21074Q28074449-02EB16C5-2048-456C-9A04-5ED7133CE2D6Q28540253-546CEF08-EA47-4F1C-AD41-335E4F16EDB4Q30276456-688FBCAF-F148-4F10-9339-A6B3B3DD519FQ34202366-1D8E7374-2566-4BBD-9B84-6F510B2B3F0AQ34447986-6136EECC-37A5-428E-BB02-20AC37AF1FADQ35920346-821E5A86-6B13-42F3-B6BD-42BE222B525AQ36568908-F018D00A-C74B-4E72-958A-1B424CC306E0Q37281443-6E8B2048-2953-4299-A2E8-F4E31A4BB377Q37831281-F6633C4B-A016-4876-980F-F6B5379C7477Q38069202-F42D26DD-D877-4A2F-9623-27C9BA79B932Q38091377-D205D79D-5811-4C37-8C6F-70F4E81D86FEQ38765132-3EB9EB52-31DA-4F63-B2C1-23612A279FEBQ38972507-FF5C6C12-D9F9-4A1A-AD6B-FF27DBA43A53Q45785797-80440511-0236-4680-82C1-B35ED73E59DFQ47131512-A6A7D194-2C4B-448C-BBA3-74B77FCBBBA4Q47872090-B9FF8D15-413E-440C-969D-596CFCFE41DBQ48206067-26B17A13-12F3-4EC1-9E69-418B95A8CB61Q49706717-BB602784-B006-4DB4-8F11-26C9B7AC0FA4Q51739297-6CE05092-8758-446C-94DB-5F045CDF86EAQ52319877-A880F3B0-2E51-484A-8337-7580002712CBQ54373272-F4B9505A-2D5C-46FB-A077-79B98CF6A913Q54942355-497746A8-361C-425F-B9B0-51DC86A33E35Q58580378-50F272FA-64D3-44C2-A6B0-DC5AD1F0B97E
P2860
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@ast
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@en
type
label
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@ast
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@en
prefLabel
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@ast
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@en
P2860
P1476
Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.
@en
P2093
Carrie Anna Geisberg
Douglas B Sawyer
P2860
P2888
P304
P356
10.1007/S11906-010-0146-Y
P577
2010-12-01T00:00:00Z
P6179
1023637230